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Degenerationlated cell self-eating process. It has been shown to be associated with various
neuropathological conditions and therefore, traditionally known as a stress-induced process. Recent studies,
however, reveal that autophagy is constitutively active in healthy neurons. Neurons are highly specialized,
post-mitotic cells that are typically composed of a soma (cell body), a dendritic tree, and an axon. Despite the
vast growth of our current knowledge of autophagy, the detailed process in such a highly differentiated cell
type remains elusive. Current evidence strongly suggests that autophagy is uniquely regulated in neurons
and is also highly adapted to local physiology in the axons. In addition, the molecular mechanism for basal
autophagy in neurons may be signiﬁcantly divergent from “classical” induced autophagy. A considerable
number of studies have increasingly shown an important role for autophagy in neurodegenerative diseases
and have explored autophagy as a potential drug target. Thus, understanding the neuronal autophagy
process will ultimately aid in drug target identiﬁcation and rational design of drug screening to combat
neurodegenerative diseases.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionAutophagy is a conserved lysosomal degradation pathway. In
mammals, three types of autophagy have been described: macro-
autophagy, microautophagy and chaperone-mediated autophagy
(CMA). These three types of autophagy differ in their mode of
delivery of their substrates to lysosomes for degradation [1]. While
little is known about the microautophagy process, a large body of
studies has contributed to the current understanding of the macro-
autophagy and CMA pathways. Macroautophagy is the prototype of
autophagy involving formation, delivery, and degradation of autop-
hagic vacuoles (also called autophagosomes) through lysosomes, and
will be the only form discussed in this review (hereafter referred to as
autophagy). Although autophagy occurs in virtually all cell types, and
likely involves highly conserved molecular machinery, emerging
evidence suggests cell type/tissue-speciﬁc regulation of autophagy.1 212 348 1310.
ll rights reserved.Neurons were one of the few cell types that were used in the initial
identiﬁcation and characterization of autophagy. With early access to
electron microscopy (EM) in the last century, Alex Novikoff, Christian
De Duve, and colleagues discovered and described the cell “self-
eating” process of autophagy in the form of distinct vacuoles through
ultrastructural analysis [2,3]. The formation of the autophagosomes,
which engulfed a portion of cytoplasm and occurred in a large
number, especially following axotomy and excitotoxic insult to
neurons, is associated with “chromatolysis”, a phenomenon that
describes the area in neuronal cytoplasm that is devoid of organelles
and ﬁlled with various types of vesicles [4]. These initial observations
of neuronal autophagic activity were followed by a series of EM
studies that revealed the accumulation of autophagosomes in the
neurons of several human neurodegenerative diseases, including
Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's
disease (HD). With little knowledge of autophagic process and
regulation, especially in mammalian tissues, neuronal autophagy,
marked by elevated levels of autophagosomes, was viewed tradition-
ally as a cellular mechanism that was highly destructive, and therefore
was suspected to be a driving force in cell death [5].
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important evidence showing that autophagy is a primary stress
response for cell survival. For example, loss-of-function studies
demonstrate the essential role for autophagy-associated genes in
the removal of “obsolete” proteins and organelles, thus protecting cell
or neuron survival [6,7]. Therefore, in injured neurons or neurons
bearing disease-related genes, altered autophagy, associated with
increased numbers of autophagosomes, can be viewed as a beneﬁcial
response of neurons in repairing or remodeling damaged cellular
components necessary for sustaining normal neuronal function and
survival. However, other studies also provide genetic and cellular
evidence that otherwise argues for a role of autophagy in promoting
neuronal death, especially in neurons with acute injury [8].
More recent studies have begun to dissect the autophagic process
in neurons under various stress or pathological conditions. These
studies suggest that, while accumulation of autophagosomes can arise
from increased production in some cases [9], it can be caused by a
mechanism that blocks fusion and degradation of autophagosomes
through lysosomes in other scenarios [10]. Given the current studies
exploring the potential of autophagy as a drug target for the treatment
of neurodegenerative diseases, a thorough investigation of the
detailed mechanism whereby autophagy participates in each disease
condition, would be critical for designing therapeutic intervention and
evaluating the efﬁcacy of an “autophagy drug” [11].
Over the past several years, characterization of autophagy in
mammalian cells and animal models has greatly advanced our
knowledge of the autophagy process in mammals. However, despite
the recent effort and exponential growth in autophagy research as a
whole, the progress in understanding the basic process and regulation
of neuronal autophagy remains relatively slow. Recent studies have
revealed the connections between autophagy and major neurological
disorders such as (AD), (PD), and (HD) [12–14]. A common theme
emerging in those studies is the role of autophagy in degrading
disease-related, aggregate-prone mutant proteins such as tau,
huntingtin and alpha-synuclein [15]. In addition, speciﬁc pathogenic
mechanisms of AD, PD, or HD may profoundly alter autophagic
activity. For example, while “inappropriate” autophagic inductionmay
contribute to the increased synthesis of β-amyloid (Aβ) [16], blocked
autophagic clearance is also implicated in cytotoxicity in AD [10].
Recently, genetic animal models containing reduced autophagic
activity were used to examine the role of autophagy in the
pathogenesis of AD, HD, and PD. These studies provided important
evidence linking dysfunctional autophagy to the speciﬁc disease
process [17,18], Friedman and Yue, unpublished). Due to numerous
recent reviews on the study of autophagy in PD, AD, or HD [12–14,19–
21], this review will instead summarize recent research in under-
standing the basis of neuronal autophagy, especially in primary
neuronal cultures and the nervous system of animal models, and
autophagic activity associated with other types of neuropathological
conditions. Although limited and sometimes conﬂicting in their
current forms, these studies nonetheless begin to shed light on
speciﬁc cellular pathways and the connection of the physiological
function of autophagy to disease mechanism.
2. Biosynthesis of autophagosomes is conserved from yeast
to human
Morphological evidence for autophagy was ﬁrst reported in the
1960s [3], but the underlying molecular mechanisms were not
elucidated for another three decades. In the early 1990s, genetic
screens of yeast mutants identiﬁed a number of autophagy-related
(ATG) genes essential for the autophagicmolecular machinery [22,23].
Currently, 31 autophagy genes are known, many of which are required
for autophagosome formation, at the nucleation, elongation, and/or
fusion steps. Upon induction, an isolation membrane or phagophore
forms and elongates, enveloping a portion of the cytosol, and enclosesto form a double-membrane vacuole. Its outer membrane subse-
quently fuses with the lysosome, where its contents, together with the
inner membrane, are digested by acidic hydrolases within the
lysosomes (Fig. 1). Up to now, at least 14 mammalian homologues
of yeast ATG genes have been identiﬁed, and characterization of their
functions suggests that the autophagic machinery is highly conserved
in mammals [24].
Studies in yeast revealed that, unlike endosomes and secretory
vesicles, autophagosome formation does not require budding from
existing organelles as its membrane source. Rather, autophagosomes
may form from de novo membrane cisternae in the pre-autophago-
somal structure (PAS), which contains several Atg protein complexes,
and resides adjacent to the yeast vacuole [25–27]. It was shown that
Atg9, the only known integral membrane protein associated with
autophagic membranes, shuttles between a peripheral site in the
cytoplasm and the PAS, therefore regulating the delivery of membrane
to the PAS for expansion [27,28]. The Atg1 kinase complex, which
contains regulatory subunit, Atg13, is involved in the retrieval of Atg9
from the PAS and is required for autophagosome formation [28,29].
Interestingly, the mammalian homologue of Atg9 (mAtg9) was shown
to cycle between the trans-Golgi network (TGN) and late endosomes,
which may serve as sources for membrane elongation. Starvation or
rapamycin treatment induced redistribution of mAtg9 from TGN to
peripheral late endosome membranes. Knock-down of Atg1 human
homolog, ULK1, prevented this starvation-induced redistribution,
suggesting that mAtg9 trafﬁcking is ULK1-dependent [30].
In addition to the recruitment of membranes, Atg9 may also play a
role in assembling protein complexes at the PAS [31]. Vps34, a class III
phosphatidylinositol (PtdIns) 3-kinase mediates vesicular trafﬁcking
through its interactions with Vps15 and Atg6, and forms two distinct
complexes: one with Atg14, which regulates autophagy-speciﬁc
function, and the other with Vps38, for endosome-to-Golgi trafﬁcking
[32]. The PtdIns 3-kinase complex produces phosphatidylinositol 3-
phosphate (PtdIns(3)P) which may recruit effector proteins, such as
the Atg18–Atg2 complex, and together, both complexes are essential
for nucleation [25]. The mammalian homologues of Vps34, Vps15 and
Atg6 are hVps34, p150 and Beclin 1, respectively. Recent studies have
found additional proteins that interact with the hVps34–p150–Beclin
1 complex: UVRAG [33], Atg14L (putative yeast Atg14 homologue)
[34] and Rubicon [35]. These studies suggest the existence of multiple
hVps34–Beclin 1 kinase complexes, which are involved in speciﬁc
membrane trafﬁcking mechanisms, including autophagy [35].
Two ubiquitin-like conjugation systems mediate autophagic
membrane elongation; one involving the conjugation of Atg5 with
Atg12 [36] and the other involving the covalent linkage of Atg8 with
phosphatidylethanolamine (PE) [37]. Both Atg12 and Atg8 modiﬁca-
tions share a single E1-like activating enzyme, Atg7, but are processed
by two separate E2-like conjugating enzymes; Atg10 and Atg3
respectively [38]. The two ubiquitin-like conjugation systems are
highly conserved fromyeast to mammals [36,39]. Themajority of Atg5
and Atg12 exists in the conjugated form and interacts noncovalently
with multimeric protein, Atg16, in yeast and its functional counter-
part, Atg16L, in mammals [40]. In one of the ﬁrst studies linking the
small GTPase Rab family to Atg proteins, Atg16L was shown to directly
interact with Golgi-resident Rab33 and modulates autophagosome
formation [41]. The Atg5–Atg12·Atg16 complex is essential for
autophagosome formation and facilitates Atg8 conjugation with PE
[40] through E3-like activity of Atg5–Atg12 for Atg8 conjugation [42].
Microtubule-associated protein 1 light chain 3 (LC3) is a
mammalian homolog of yeast Atg8 and is cleaved at its C-terminal
region by cysteine protease Atg4. This processed form (LC3-I) resides
in the cytoplasm until it undergoes two ubiquitin-likemodiﬁcations to
become covalently linked to PE. Both the lipidated form LC3 (termed
LC3-II) and Atg12–Atg5·Atg16 are recruited to the isolation mem-
brane [38]. Whereas Atg12–Atg5·Atg16 dissociates upon autophago-
some completion, LC3-II remains coupled to the autophagic
Fig. 1. A schematic representation of the macroautophagy process. Following induction, a phagophore or isolation membrane is formed. This process is regulated by Atg1 (Ulk1),
Atg9, and the PtdIns 3-kinase complex, which includes Beclin 1, Atg14L, and UVRAG (nucleation). Two ubiquitin-like conjugation systems, which produce Atg8-PE (LC3II) and Atg5–
Atg12, mediate the elongation of the isolation membrane, closure, and the formation a double-membrane vacuole known as the autophagosome. Autophagosomes can undergo
maturation and fusion with early and late endosomes and MVBs, to generate the amphisome, followed by fusion with lysosomes, to form the autolysosome. Trafﬁcking, maturation,
and fusion events aremediated bymicrotubules and speciﬁc SNARE and Rab proteins. ESCRT proteins are also essential for MVB fusionwith autophagosomes. Alternatively, immature
autophagosomes can fuse directly with lysosomes.
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event, autophagosomes undergo a maturation process involving
fusionwith early and late endosomes, including multivesicular bodies
(MVB), to form amphisomes [43]. Subsequently, these vacuolar bodies
can then fuse with lysosomes to form the autolysosome (Fig. 1). These
fusion events are mediated by SNARE proteins and Rab proteins,
speciﬁcally Rab7, which is essential for maturation [44,45].
3. Neuronal autophagy: process and function in health and disease
3.1. Basal level autophagy
3.1.1. Unique feature of neuronal autophagy: scarcity of autophagosomes
Previous studies using mice expressing an autophagosomemarker,
green ﬂuorescent protein-tagged LC3 (GFP-LC3), suggested that
autophagy is distinctly regulated in different tissues [46]. For example,
food limitation triggers a rapid upregulation of autophagy in liver and
heart as indicated by the formation of a large number of GFP-LC3-
associated autophagosomes, whereas it fails to induce GFP-LC3-
labeled autophagosomes in the CNS, despite the strong expression of
GFP-LC3 in many types of neurons. In addition, LC3 exists predomi-
nantly in a soluble form (LC3-I) in healthy neurons, and levels of the
lipidated form (LC3-II) do not change after starvation [46]. Recently,
we have investigated the localization of GFP-Atg5, a green ﬂuorescent
Atg5 fusion protein used for monitoring isolation membrane, in CNS
neurons of transgenic mice [47], and the results show that like GFP-
LC3, GFP-Atg5 is largely diffuse regardless of whether food is available
or withdrawn (Yue, unpublished data). Indeed, ultrastructural
analysis also conﬁrmed scarcity of double-membrane vacuoles thatare characteristic of autophagosomes in healthy neurons [48]. In
contrast, many tissues, including liver and heart, have many GFP-LC3
puncta even when food is not limited, thus providing direct evidence
for constitutively active autophagy under normal conditions.
The above evidence suggests that neurons normally maintain low
levels of autophagosomes, and perhaps a low rate of autophagosome
biosynthesis, even with the ﬂuctuation of available nutrients. The
current hypothesis is that neurons are prohibited from large-scale
autophagy induction in response to starvation due to their ability to
utilize multiple energy sources to maintain normal neuronal function.
For example, glial cells provide nutrient and neurotrophin support to
neurons and peripheral organs supply necessary nutrients to the CNS
under hypothalamic regulation [49]. Thus, it is possible that even after
48 h of fasting in mice, it is insufﬁcient to cause nutrient or trophic
factor depletion in the CNS neurons due to compensatorymechanisms
of nutrient supply. Interestingly, without showing the availability of
nutrient or trophic factors, a recent study reported that mTOR activity
(an important regulator of autophagy) was signiﬁcantly reduced, at
least in hypothalamic neurons, after 48 h of starvation in mice [50].
Despite the reduced mTOR activity, there was no report of the
formation of GFP-LC3 or GFP-Atg5 puncta in hypothalamic neurons
(Yue, unpublished data), [46]. While the mTOR activity in hypotha-
lamic neurons of GFP-LC3 or GFP-Atg5 transgenic mice after 48 hour-
starvation remains to be determined, other studies observed mTOR-
independent regulation of autophagy in neurons [51,52]. Importantly,
Young et al., showed that insulin plays a critical role in suppressing the
induction of autophagy in primary neuron cultures. Through screen-
ing culture medium components, they found that insulin (but not
other components, including amino acids) was the key factor and that
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mTOR-dependent manner. Surprisingly, a highly potent Akt inhibitor
also efﬁciently induces autophagy, however, via an mTOR-indepen-
dent pathway [51]. This result suggests that the active insulin
signaling is responsible for the low level of autophagosome formation
in healthy neurons, and therefore, the insulin pathway may provide a
critical mechanism for controlling basal autophagy in neurons.
Although the autophagy control mediated by insulin signaling is not
restricted to neurons [53], it can be adapted to the neuronal
physiology that is related to the high consumption of energy via
distinct sources. In addition, multiple parallel signaling pathways,
including the mTOR pathway, exist in neurons to regulate autophagy.
Apart from the insulin pathway, speciﬁc proteins or protein
modiﬁcations expressed in neurons may also contribute to additional
regulation of basal autophagy in neurons. Previously, we showed that
expression of a microtubule associated protein 1B (MAP1B), which is
enriched in neurons and binds LC3 with high afﬁnity, remarkably
affects the formation of GFP-LC3 puncta (autophagosomes), and this
effect is dependent on the status of certain modiﬁcations of MAP1B
[54], (see section 4.2 of this review).
Taken together, we propose that the regulation of basal autophagy
in CNS neurons at least involves the following mechanisms: (1) a
non-cell-autonomous mechanism whereby nutrients, hormones
(insulin), or neurotrophic factors are supplied by peripheral organs
or glial cells, (2) a cell-autonomous control mechanism by intrinsic
nutrient-mediated signaling or speciﬁc factors expressed in neurons.
Furthermore, current evidence also raises the question as to what
context or extent does mTOR-mediated signaling regulates autophagy
in neurons.
While the hypothesis for the low level of basal autophagy (in the
form of “classical” autophagosomes) and its regulation remains to be
tested further, a recent study provides evidence suggesting an
alternative hypothesis that autophagosomes, once formed, are rapidly
cleared by fusion with lysosomes in primary neuronal culture. It
further proposes that the clearance of autophagosomes by basal
autophagy is highly efﬁcient in neurons and accounts for the low
levels of autophagosomes [10]. Apparently, future experiments
focused on directly measuring or imaging the dynamics of autophagy
ﬂux will be needed to solve this issue.
3.1.2. Essential role of basal autophagy in cellular homeostasis and
neuroprotection
Current evidence suggests that neuronal autophagy is tightly
regulated and autophagosomes are maintained at minimal levels.
However, recent studies in mutant mice with targeted deletion of Atg5
or Atg7 speciﬁcally in brain, unequivocally demonstrate the impor-
tance of basal autophagy in CNS neurons [6,7]. Unlike Atg5- or Atg7-
deﬁcient yeast or mammalian MEF cells that survive and grow
normally with regular culture conditions, CNS neurons lacking Atg5 or
Atg7 in animal models undergo progressive degeneration, even when
mice are housed under normal conditions. Importantly, Atg5 or Atg7
deﬁcient neurons develop a massive number of inclusion bodies that
are labeled by ubiquitin, suggesting that continuous autophagy is
required to prevent the build-up of intracytoplasmic protein aggrega-
tion. These studies provide undeniable proof for the existence and
critical function of basal autophagy in neurons. Paradoxically, the
evidence that autophagy is in continuous action through autophago-
some–lysosome degradation is at odds with the scarcity of autopha-
gosomes or low level of basal autophagy in the healthy neurons.
Although it appears to be consistent with the hypothesis of highly
efﬁcient basal autophagy [10], an alternative hypothesis is that basal
autophagy in neurons proceeds via a distinctive mechanism (e.g. in
the absence of “classical” autophagosomes formation). Even though
autophagy genes (ATG system) are required, they participate in the
lysosomal degradation pathway that differs from canonical autophagy
(in the presence of well-documented autophagosome formation)[55]. One well-known example for such an autophagy-related cellular
process, is the yeast Cvt (cytoplasm-to-vacuole targeting) pathway,
which shares most of its protein components with autophagy, but is
biosynthetic and functions to speciﬁcally deliver certain enzymes to
vacuoles [56]. Future studies should investigate the possibility of non-
canonical or adapted autophagy in neurons.
Although CNS neurons are generally vulnerable to the loss of the
autophagy pathway, the degree of vulnerability and the formation of
intracellular inclusions vary signiﬁcantly among different neuron
types as observed in the mutant brains deﬁcient in Atg5 or Atg7. The
ablation of the Atg5 or Atg7 gene may trigger a cell-type speciﬁc
cellular response to autophagy deﬁciency and/or a cell type-
dependent mechanism contributing to the neurotoxicity. For example,
Purkinje cells deﬁcient in Atg5 or Atg7 display very few ubiquitin-
associated inclusions, whereas these cells are among the most
vulnerable neuron types [57,58]. In contrast, a large number of
ubiquitin-associated inclusions are seen in the brain region where
neuronal loss was hardly detected when autophagy was genetically
inhibited (Waguri S, Komatsu M, unpublished data). While it is
possible that the compensatory pathways to the loss of autophagy
vary in different neuronal types and account for the difference in their
vulnerability, it may also reﬂect the disparity in their intrinsic
demands for autophagy, as well as relative levels of basal autophagy.
Neurons exposed to high levels of various stresses may contain high
levels of basal autophagy and are therefore, far more vulnerable,
whereas the neurons that require low levels of basal autophagy
through their lives are relatively resistant to autophagy deﬁciency.
3.2. Induced autophagy in neurons: signaling and distinctive stress
response
The primary function of autophagy is to provide cellular response
to nutrient limitation by mobilization of autophagosome–lysosome
degradation pathway. A large body of evidence shows that nutrient-
related signaling pathways regulate autophagic activity in mammals.
These pathways include insulin and amino acid pathways, mTOR
kinase complex [59–61], AMP-activated protein kinase (AMPK) [62]
and Beclin 1/Vps34 (class III PI-3 kinase, PtdIns3K) lipid kinase
complex [63]. Despite the growing evidence linking these signaling
pathways to autophagy regulation, the details for how they control the
complex process of autophagy is lacking. Furthermore, little is known
about tissue/cell type-dependent regulation. A recent study in
primary cortical neuronal culture shows that insulin plays a critical
role in controlling the induction of autophagy [51].
A unique feature of neurons, with respect to their fuel supply, is
that they use glucose (or ketones) almost exclusively as a blood-borne
energy substrate to provide energy and carbon chains for protein
synthesis. Therefore, compared to other tissues/cell types, CNS
neurons may depend less on autophagy to provide free amino acids
or energy under physiological conditions. It can be further speculated
that the primary function of neuronal autophagy at the basal level is
different than as a primary nutrient-starvation response [49].
Accordingly, neurons are likely to use a distinctive mechanism for
autophagy regulation. Adding to the complexity of autophagy
regulation in neurons, a recent study shows that cultured neurons
frommale rats more readily undergo autophagy in response to 24 h of
nutrient deprivation compared to female neurons [64], indicating
gender differences in autophagic capacity of neurons.
While nutrient-related pathways are likely the conservedmechan-
ism for the control of neuronal autophagy [10,51], the direct in vivo
evidence that these pathways contribute to the induction of
autophagy (e.g. synthesis of a large number of autophagosomes) in
CNS neurons remains to be shown. Despite the lack of in vivo evidence
of neuronal autophagy mediated by nutrient signaling, recent studies
in animal models indicate that, in contrast to nutrient starvation
which rarely induces autophagy, a variety of stress-related signals,
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tion and accumulation of autophagosomes in neurons. As a result, the
intracytoplasmic area occupied by autophagic activity is sharply
increased and the capacity of autophagic degradation could be
maximally expanded. During the process of autophagy induction,
neurons may undergo a signiﬁcant change in autophagy regulation,
involving a deregulation process that allows neurons to transition
from basal level (neuron-speciﬁc process) to the activated state (well-
conserved and known as induced autophagy) involving large-scale
biosynthesis of autophagosomes. Here we summarize some examples
of induced autophagy in neurons.
3.2.1. Hypoxic-ischemia
A combined hypoxic-ischemia (H/I) procedure in rodents has been
widely used as a model for studying human ischemia or stroke. H/I
causes extensive CNS neuron damage or injury and consequent
neuronal death. Two recent studies of mouse models, one in neonatal
brains [8] and the other in adult brains [65], showed that H/I induced
robust formation of autophagosomes within a very short period of
time (hours), concomitant with increased production of LC3-II levels.
This induced autophagy occurred in different types of neurons in the
hippocampus and striatum, suggesting that it is not cell type-speciﬁc.
The rapid appearance of autophagic hallmarks in these two in vivo
models demonstrated that H/I is a powerful stimulus for autophagy
induction in CNS neurons. At the cellular level, H/I produces pro-
inﬂammatory cytokines and simultaneous activation of both pro-
survival (e.g., upregulation of Hsp70, phosphorylation of ERK and
AKT) and pro-apoptotic signaling pathways (e.g., release of cyto-
chrome c and AIF from mitochondria, cleavage of caspase-9 and -8)
[65]. Therefore, at present, it is unknown which signals of autophagy
induction are triggered by the H/I procedure. Interestingly, Koike et al.
further demonstrates that mice deﬁcient in essential autophagy gene,
Atg7, show nearly complete protection from H/I-induced neuron
death, arguing strongly for the involvement of autophagy in a pro-
death pathway in this speciﬁc setting [8]. Although the signiﬁcant role
of autophagy in triggering cell death pathways has yet to be clariﬁed,
this study suggests that H/I-induced autophagy, rather than an
epiphenomenon of neuronal death, is an active process that controls
cell fate. More importantly, inhibition of autophagy represents an
attractive strategy for drug design in alleviating neuronal damage
associated with H/I injury.
3.2.2. Excitotoxic stimuli
Many excitotoxic stimuli provoke neurodegeneration through
poorly deﬁned cell mechanisms. The Clarke group has previously
used NMDA (glutamate mimetic)-treated organotypic hippocampal
slices to investigate this mechanism [66]. They found that, within 2 h
following the drug administration, numerous autophagosomes
appeared in CA1 and CA3 pyramidal neurons, concomitant with
signs of neurodegeneration. Moreover, this induction of autophago-
some formation was inhibited by treatment of a JNK-signal blocking
peptide, which also prevented neuronal death [66]. In another
excitotoxicity-related model with focal injection of kainic acid,
hippocampal extracts contain a signiﬁcant increase in LC3-II levels
as early as 4 h following the injection [67]. Consistent with autophagic
activity elicited in hippocampus, local administration of kainic acid
caused a rapid increase in autophagosomes and autolysosome
formation in the cytoplasm of striatal cells. In addition, it also
augmented the ratio of LC3-II/LC3-I, LAMP2, cathepsin B, release of
cytochrome c, and activation of caspase-3, suggesting stimulation of
both apoptosis and autophagy [68]. Pre-treatment of autophagy
inhibitor 3-methyladenine (3-MA) reversed the change in LC3-II
levels, autophagosome formation, and loss of striatal cells [68]. In
Lurchermice, a genetic mouse model of excitotoxicity associated with
Purkinje cell-speciﬁc degeneration, constitutive activation of gluta-
mate δ2 receptor results in autophagy induction, preceding Purkinjecell degeneration. Moreover, the mutant glutamate δ2 receptor-
mediated cell toxicity in transfected cells was blocked with autophagy
inhibitor 3-MA [69].
Current knowledge indicates that excitotoxicity occurs when
excitatory glutamate receptors, such as those for NMDA or kainic
acid, are overexcited by high dosage of these ligands. The activated
receptors allow the receptor channels to open, resulting in Ca2+ inﬂux
and consequent activation of a number of enzymes, including
phospholipases, endonucleases, and proteases, such as calpain. Recent
studies show that Ca2+ triggers strong stimulation of autophagic
activity [70]. Therefore, it is possible that excitotoxic-related signals
induce elevated levels of autophagy by a common Ca2+-mediated
pathway. Furthermore, the above studies suggest that manipulation of
autophagy, by blocking its activation, may be beneﬁcial in the
treatment of excitotoxic-associated neuronal death.
3.2.3. Methamphetamine and MPP+
Administration of methamphetamine (METH) in animals generally
produces selective degeneration of dopamine (DA) neuron terminals
without signiﬁcant cell body loss [71]. This model is currently used to
study speciﬁc aspects of neuron terminal dystrophy and degeneration
in PD. To investigate the mechanism underlying the METH-mediated
toxicity, the Sulzer group found that METH treatment promoted the
rapid formation of autophagosomes, particularly in neuronal varicos-
ities and, ultimately, within cell bodies of DA neurons from midbrain
neuronal cultures [72]. A recent study in PC12 cells showed a similar
response to METH administration, and provided additional evidence
that suppression of autophagy, by blocking PI-3K class III activity,
precipitates neuronal death. This study implicates a beneﬁcial role of
METH-induced autophagy in neural protection, perhaps through
repairing or remodeling injured neurons [73].
A related PD cell model is the treatment of the neurotoxin 1-
methyl-4-phenylpyridinium (MPP+), which produces mitochondria-
targeted injury and contributes to parkinsonism induced by 1-methyl-
4-phenyl-1,2,3,6-tetrahydro-pyridine in mammals. Administration of
MPP+ in primary DA neuronal culture elicited an increased proﬁle of
intracellular autophagosomes, which was suppressed by extracellular
signal-regulated protein kinase (ERK) kinase, a MEK inhibitor [74].
However, it is unclear why 3-MA, an inhibitor for autophagy, did not
impede autophagosome formation induced by MPP+ in this setting.
Interestingly, RNAi knock-down of autophagy gene LC3 or block of
MEK with a speciﬁc inhibitor in MPP+-treated human neuroblastoma
SH-SY5Y cells reduced formation of autophagosomes and cell death.
One plausible explanation for MPP+-induced autophagy is through
injured mitochondria, which elicited signals involving MEK for
increased autophagic activity. Although the result shows that reduced
autophagy is correlated with delay of cell death, whether or not
autophagy acts as an executor of cell death is unclear [74].
3.2.4. Proteasome inhibition: a compensatory induction
Emerging evidence implicates inhibition of the ubiquitin–protea-
some system (UPS) in neurodegenerative diseases, such as AD and PD.
Autophagy-lysosomal degradation and UPS are the two major
proteolytic pathways, but they differ in various aspects including
their substrates, capacity, and molecular and cellular machinery.
Previous study of the effects of chronic low-level proteasome
inhibition on neural homeostasis indicated that inhibition of UPS
causes increased autophagic activity in clonal SH-SY5Y cells [75]. The
view that increased autophagic activity is a compensatory response of
impaired UPS system is supported by a few other studies. Pandey et al.
used the ﬂy genetic system to provide in vivo evidence that
signiﬁcantly strengthened and expanded this view. They showed
that histone deacetylase 6 (HDAC6), a microtubule-associated deace-
tylase that interacts with polyubiquitinated proteins, plays a critical
role in this compensated induction of autophagy for impaired UPS
function.Moreover, they found that forced expression of HDAC6 is able
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autophagy-dependent fashion [76]. This study raises an important
question regarding the cross-talk between the two main cellular
degradation routes – autophagy and UPS – and whether or not HDAC6
is positioned at the intersection of these two pathways. Interestingly, a
more recent report shows that genetic deletion of 26S proteasomes in
mouse brain causes neurodegeneration and Lewy-like inclusions in
midbrain DA neurons, which is accompanied by increased expression
of autophagy genes and formation of numerous vacuoles resembling
autophagosomes [77]. Although the mechanism of interaction
between the twopathways is unclear, the compensatory up-regulation
of autophagy for degradation of protein aggregates, which normally
exceed the capacity of UPS degradation, should be explored as drug
target for the treatment of neurodegenerative diseases.
3.2.5. Lysosomal enzyme/lipid storage or suppression: autophagy
“vicious circle”
A number of studies exploring autophagy in lysosome-related
neurological diseases provide a new understanding of the pathogenic
mechanisms of “old” diseases. A subset of these diseases, also known
as lysosomal storage disease, is caused by deﬁciencies of lysosomal
hydrolases, resulting in accumulation of undigested materials in the
lysosomal or related compartment. These disorders include Niemann–
Pick type C (NPC) [78,79], mucolipidosis type IV with mutations in
Mucolipin 1 (MCOLN1), multiple sulfatase deﬁciency and mucopoly-
saccharidosis type IIIA [80]. A common cellular pathologic feature in
these diseases and their animal models is the manifestation of
aberrant autophagic activity as evidenced by the accumulation of
autophagosomes and increased levels of LC3-II, accompanied by
neurodegeneration. Direct deletion of the genes encoding lysosomal
enzymes such as cathepsin D (CD−/−) or combination of cathepsin B
and L (CB−/− and CL−/−) in mouse brain, resulted in a similar
phenotype [81]. The current view is that lipid trafﬁcking molecules or
lysosomal enzymes are required for the delivery, fusion or clearance of
autophagosomes; deﬁciencies in these molecules causes disruption of
this process, resulting in build-up of autophagosomes/autolysosomes
unable to complete the digestion. This view supports a hypothesis that
impaired autophagic activity is part of the disease mechanism for
lysosomal storage diseases due to the inability of neurons to clear
autophagosomes. However, these studies also provide evidence that
otherwise amends this hypothesis. Pacheco et al. showed that, in
addition to impaired autophagy ﬂux, there is also induction of
autophagy in NPC by signaling through a complex of the class III
phosphoinositide 3-kinase/beclin-1 [79]. A signiﬁcant number of
nascent autophagosomes (immature or before fusionwith lysosomes)
are found in CD−/− or CB−/− and CL−/− brains, suggesting that
they are newly synthesized autophagosomes [81]. In a study of
ﬁbroblasts obtained from patients carrying mucolipidosis type IV
mutation, Vergarajauregui et al. suggest that the autophagosome
accumulation is due to increased de novo autophagosome formation
and delayed fusion of autophagosomes with late endosomes/lyso-
somes [80]. Therefore, the available evidence indicates that there is
induced synthesis of autophagosomes in addition to the compromised
autophagosome fusion or clearance in lysosomal storage diseases.
The deﬁciency in lysosomal degradation is expected to affect the
net outcome of all forms of autophagy, including macroautophagy,
microautophagy and chaperon-mediated autophagy. In line with the
concept that blocking one type of degradation (e.g., proteasome or
CMA) stimulates compensatory pathways (e.g. autophagy), intracel-
lular accumulation of non-degraded materials resulting from lysoso-
mal enzyme deﬁciency is expected to feed back to the upstream
signaling which triggers the biosynthesis of autophagosomes. Since
autophagosome degradation through lysosomes is impaired, it creates
a “dilemma” for neurons to dispose autophagosomes, amassing a large
number of autophagosomes of various stages. Thus, we propose a
hypothesis that explains the sequence of the events in the disease,considering lack of detectable autophagosomes in healthy neuron. The
accumulation of undigested materials due to lysosomal deﬁciency
triggers de novo autophagosome biosynthesis in lysosomal storage
disease. Impaired lysosomal degradation will trap these autophago-
somes, causing build-up of the induced autophagosomes, and more
undigested materials. This can continue in circles, and as a result of
this rampant autophagy “vicious circle”, neurons may exhaust their
energy and generate various toxic species that are harmful.
3.3. ESCRT: autophagy meets endocytosis
Previous studies from the Seglen group showed that autophago-
somes can fuse with endosomes and form a hybrid product, termed
amphisomes, providing early evidence of interaction between
autophagy and endocytosis [82]. Although this observation suggests
the convergence of autophagosomes and endosomes, perhaps under
speciﬁc settings, the signiﬁcance of this process has not been fully
appreciated. Recently, several studies showed that mutations in
CHMP2B, a subunit of the endosome sorting complex required for
transport (ESCRT)-III, are linked to frontotemporal dementia (FTD)
and amyotrophic lateral sclerosis (ALS) and prevents autophagic
degradation [83]. Along with these studies, genetic and ultrastructural
analysis in Drosophila melanogaster showed that subunits of the
ESCRT- I, -II and -III, as well as their regulatory ATPase Vps4 and the
endosomal PtdIns(3)P 5-kinase Fab1, are all required for normal
autophagy function [84,85]. These studies are important in several
aspects. First, they reveal a novel mechanism involving dysfunctional
autophagy in the pathogenesis of speciﬁc types of FTD and ALS.
Second, since the ESCRT proteins are known to function in the sorting
of transmembrane proteins into the inner vesicles of the multi-
vesicular body (MVB) during endocytosis [86], these studies suggest
that MVB or endocytic pathways are critical routes for the trafﬁcking
of autophagosomes to lysosomes, and defective ESCRT function
prevents fusion or maturation of autophagosomes. Third, they suggest
that neurons are particularly vulnerable to abnormal function in the
autophagosome-MVB (endosomes) pathway, and this may be
associated with dendritic maintenance [83].
Several outstanding questions, however, arise from these studies.
The ESCRT machinery is evolutionarily conserved [86], and its
function inMVB biogenesis has been shown inmany species including
yeast and human. Curiously, although ESCRT/MVB, as well as
autophagy, are highly conserved and well-characterized in yeast, the
interaction between ESCRT/MVB and autophagy has not been
demonstrated. Therefore, it raises a question whether the ESCRT-
MVB pathway is only important for autophagy in higher eukaryotes,
including ﬂy and mammals. Furthermore, amphisomes are not
detected in yeast, and autophagosomes fuse directly with the vacuole,
which is mediated by SNARE proteins [87]. A related question is
whether ESCRT-MVB represents the primary, if not the only, route for
delivery of autophagosomes to lysosomal degradation, and whether
this route occurs only in speciﬁc cell/tissue context. Previous studies
also suggest that a considerable proportion of endocytosed cargo
merges with autophagic pathway prior to being degraded by
lysosomes in neurons [20].
It is also conceivable that the ESCRT-MVB pathway is actually part
of the yet-to-be-deﬁned basal autophagy process in neurons. Forma-
tion of ubiquitin- or p62/SQSTM1-labeled inclusions and autophago-
somes accumulation are two important features associated with cells
or neurons deﬁcient in ESCRT components. Interestingly, time-course
studies show that the formation of ubiquitinated inclusions occurs
prior to the appearance of autophagosomes in cortical neuronal
culture expressing mSnf7-2 siRNA or CHMP-2Bintron5. The early
formation of ubiquitinated protein inclusions in these neurons
defective in ESCRT function phenocopies results from Atg5 or Atg7
deﬁcient neurons [6,7], suggesting that the ESCRT-MVB pathway is
likely related to the Atg5 or Atg7-regulated function, which is required
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function. Since impaired ESCRT pathway does not affect biosynthesis
of autophagosomes (unlike Atg5 or Atg7), autophagosome biosynth-
esis is induced as a response to the increasing levels of ubiquitinated
proteins. Thus, an alternative hypothesis is that formation of
ubiquitin- or p62-labeled protein inclusions is the early response of
neurons to the deﬁciency in basal autophagy caused by dysfunctional
ESCRT, whereas the accumulation of autophagosomes is the secondary
response to the increased levels of undigested protein and/or a result
of impaired ESCRT function, which may be related to autophagosome
fusion or maturation. The relationship of ESCRT with basal autophagy
should be explored in the future.
4. Specialized neuronal autophagy in the axons
4.1. Role of neuronal autophagy in axonal homeostasis
The axon is a highly specialized neuronal compartment that
performs many functions independently from the soma. Accumulat-
ing evidence has revealed that, not only is autophagy uniquely
regulated in the neuron, but it may also have a distinct function and
regulation within the axonal compartment, independent from the
dendrites and soma. Early morphological evidence showed that,
following axotomy [88] or excitotoxic injury [4], double-membrane
vacuoles resembling autophagosomes started accumulating and
localized in dilated axon terminals. In later studies, Hollenbeck
described the sequestering of autophagic substrates in autophago-
somes at the most distal region of the axon, which were retrogradely
transported to the soma [89]. Mammalian autophagosomes form in
various regions throughout the cytoplasm. Upon maturation, they
move toward lysosomes, which are primarily located in the juxta-
nuclear cytoplasm of the cell body [90,91]. More recently, autophago-
some formation in response to an excitotoxic insult was monitored in
Lurcher mice expressing GFP-LC3. The constitutive activation of the
GluRδ2 receptor resulted in an excitotoxic injury that triggered a rapid
and robust accumulation of GFP-LC3-labeled autophagosomes in
axonal dystrophic swellings [54]. The link between increased
autophagy activity and axonal dystrophy would suggest local
biosynthesis of autophagosomes at the distal axon terminals.
To elucidate the physiological role of neuronal autophagy, mutant
mice containing a neural cell type-speciﬁc deletion of Atg7 were
generated. Establishment of these mutant mice allowed the study of
cell-autonomous events in cerebellar Purkinje cells deﬁcient in
autophagy. Characterization of the mutant Purkinje cells revealed
the accumulation of aberrant organelles and membrane structures in
dystrophic axon terminals. This result suggests a speciﬁc role for
neuronal autophagy in the maintenance of membrane homeostasis at
the axon terminal. We hypothesize that this highly specialized
neuronal autophagy is required for keeping the balance of the
membrane network, which normally involves cycling of membranous
structures or vesicles, at the axon terminals to support synaptic
activity. This particular function of autophagy is no surprise consider-
ing that the typical autophagic process involves dynamic membrane
rearrangement and turnover. Future study should investigate in detail
how this “self-eating” process participates in axonal membrane
turnover and what membrane substrates axonal autophagy removes
under physiological conditions. The answers to these questions are
expected to advance our current understanding of autophagy in the
neuron, as well as the disease processes that are associated with
dysfunctional autophagy in the neuron and the axon.
4.2. MAP1B–LC3 interaction regulates autophagosome formation and
possibly axonal transport
LC3 is best known as an autophagosome-associated protein.
Despite the abundance of LC3 in neurons, the vast majority of LC3 isin soluble form and is not associated with autophagosomes. To
understand neuron-speciﬁc autophagosome formation, Wang et al.
identiﬁed and analyzed the interaction between LC3 andmicrotubule-
associated protein 1B (MAP1B), which is an abundant protein in the
axons and plays an important role in regulating microtubule stability.
They found that MAP1B binds to LC3 with high afﬁnity, and over-
expression of MAP1B in non-neuronal cell culture signiﬁcantly
reduces the number of LC3-associated autophagosomes, presumably
through the MAP1B–LC3 interaction [54]. Since MAP1B (or MAP1A) is
highly expressed in neurons, this result may potentially explain the
scarcity of the autophagosomes in healthy neurons and the lack of
GFP-LC3 puncta in GFP-LC3 transgenic brain. In contrast to MAP1B,
phosphorylated MAP1B (MAP1B-P) was found to be associated with
LC3-autophagosomes. It was further shown that LC3 was associated
with increased levels of MAP1B-P in dystrophic axon terminals,
coincident with the presence of a large number of autophagosomes
[54]. Moreover, during development, MAP1B-P is highly expressed
and is most concentrated in the distal axons of growing neurons [92].
The conserved role of MAP1B-P in axonal growth or repair during
development or injury implicates autophagy in the remodeling of
axon terminal structures for regeneration. Thus, we propose that
interactions of LC3 with MAP1B or MAP1B-P provide a mechanism
that regulates autophagosome formation in neurons or the axons.
The hypothesis that neuronal autophagy maintains axonal
homeostasis is also in line with the idea that autophagy substrates
are removed from the axons through axonal transport back to the
soma where lysosomes perform degradation [89,93]. Interestingly,
recent studies have revealed a role of MAP1B in retrograde axonal
transport [54]. It is possible that the MAP1B-P–LC3 interaction may
regulate axonal transport of “autophagic cargo”. In support of this
idea, microtubules and the dynein motor complex were previously
shown to be required for autophagy process [90]. Dynein, the
minus-end directed motor protein, mediates retrograde transport
and interacts with the dynactin protein complex, which is
implicated in cargo binding [94]. Inhibition of dynein impeded
rapid movement of autophagosomes in mouse embryonic ﬁbroblasts
(MEF) cells and inhibited clearance of mutated alpha-synuclein or
huntingtin by preventing fusion with the lysosome [90,95].
Furthermore, microtubule networks may facilitate the transport of
LC3-positive autophagosomes [96], but are not required for fusion
with lysosomes [54,97,98].
Although limited, recent studies involving live imaging showed
that GFP-LC3 “dots” undergo retrograde transport in primary
cerebellar granule cells [93]. In addition, both anterograde and
retrograde transport of GFP-LC3-labeled autophagosomes were
detected in neurites of differentiated PC12 and normal rat kidney
cells [91,99]. Although bidirectional movement was observed, Jahreiss
et al. propose an overall bias for microtubule-dependent movement
toward the nucleus, which is mediated by dynein [91]. In summary,
we anticipate that future study, using live-imaging, should elucidate
the dynamic process of autophagy in neuron or axon.
4.3. Ulk1 and axonal autophagy
Additional evidence supporting the hypothesis that autophagy is
important in axonal transport and function comes from the study of
yeast Atg1 and its homologue, Unc-51 (C. elegans uncoordinated-51).
Atg1/Unc-51 is a highly conserved serine/threonine kinase. In initial
C. elegans screenings, unc-51 mutants displayed disruptions in axon
ultrastructure, including the presence of abnormal membranous
structures in the axon and large swellings in the terminal [100]. The
murine homologue, Unc51.1, is required for neurite extension in
primary cerebellar granule neurons and governs vesicular membrane
organization during outgrowth [101]. Thus, Unc-51 may provide a
potential link between local membrane dynamics and autophagy at
the axon terminal. Interestingly, the human homolog, Unc-51-like
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Golgi-associated ATPase enhancer (GATE-16) and GABAA receptor
associated protein (GABARAP), and have recently been shown to
associate with p62/SQSTM1 [102,103]. Nerve growth factor (NGF)
binding with TrkA receptors facilitates K-63 polyubiquitination of
ULK1, promoting its associationwith the UBA domain of p62/SQSTM1
and recruiting ULK1 into the active TrkA complex. ULK1 interacts with
syntenin and SynGAP (which regulate endocytosis) and results in the
trafﬁcking of NGF-bound TrkA receptors into endocytic vesicles [104].
These results provide a possible mechanism for the cross-talk
between two important membrane trafﬁcking pathways – autophagy
and endocytosis – and their role in axonal physiology. One possibility
is that, by fusion with autophagosomes, some types of membrane
compartments, including endosomes, are removed from the axons
and delivered to lysosomes for degradation. This process may be
essential to maintain the homeostasis of the axonal membrane
network [58].
4.4. Axonal autophagy and axonopathy
Axonal dystrophy, a hallmark of axonopathy, can be triggered by
neuronal injuries, excitotoxicity, and various neurodegenerative
conditions. Despite the prevalence of this pathology, the molecular
mechanisms underlying axonopathy, as well as the connection
between axonopathy and neurodegeneration, remain poorly under-
stood. Dysfunctional autophagy has recently been implicated in
axonal dystrophy. Severe axonal swellings were observed when
autophagy was suppressed in the mouse brain [6,7]. Genetic ablation
of Atg7, speciﬁcally in Purkinje cells of mutant mice, however, resulted
in cell-autonomous axonal dystrophy and degeneration, implying an
essential role for autophagy in membrane trafﬁcking and turnover in
axons. In contrast to Lurcher mice, axon terminals of Atg7 deﬁcient
mice lacked autophagosome-like vesicles, but amassed abnormal
organelles and membranous structures [58]. Moreover, mice with
Purkinje-cell speciﬁc deletion of either Atg5 or Atg7, exhibited axonal
dystrophy much earlier than dendritic tree atrophy and cell death
[57,58]. Thus, overactive or insufﬁcient autophagy may contribute to
axonopathy, which is a prominent feature of human neuropathology.
Accumulating evidence indicates that axonal degeneration pre-
cedes neuronal cell body death and undergoes a self-destruct
mechanism that is distinct from apoptotic death in the soma
[105,106]. A classic example of axonal degeneration is WallerianFig. 2. Proposed model for neuronal autophagy in the axons. Under normal conditions, basa
“autophagic cargo” undergoes retrograde axonal transport to the soma and fuses with lysoso
resulting in their accumulation in axons and axon terminals. It has been suggested that, u
anterogradely transported to the axon terminal and contribute to the degradation of autopha
aberrant membrane structures at axon terminals, resulting in gross axonal swellings or dysdegeneration, in which transected axons or neurites undergo
complete fragmentation distal to the site of injury [106]. In mice
carrying the spontaneous-occurring slow Wallerian degeneration
(Wlds) mutation, Wallerian degeneration is markedly delayed
following transection. However, the “dying back” model, a progres-
sive retrograde degeneration of the distal axon, may better reﬂect
the chronic injury associated with neurodegenerative diseases [106].
NGF deprivation induced accumulation of autophagosomes in the
distal tips of PC12 neurites supporting the hypothesis that
autophagy induction contributes to dying back degeneration in
which distal neurites are more fragile than proximal segments.
Indeed, knocking down levels of Atg7 or Beclin1 caused a signiﬁcant
delay of neurite degeneration after NGF deprivation in sympathetic
neurons [107]. These ﬁndings suggest that autophagy activation
contributes to neurite degeneration, thus providing a valuable clue
about the possible involvement of autophagy in the mechanism of
axonal degeneration.
In summary, based on current evidence, we propose that basal
autophagy plays an important role in the maintenance of axonal
homeostasis by the removal of “autophagic cargo” from distal axons
or terminals through retrograde axonal transport. Although the
“autophagic cargo” can be associated with LC3, it is largely unclear
whether they are in the form of typical autophagosomes [55]. Future
study should investigate the nature of “autophagic cargo” in healthy
neurons or axons. In contrast, pathological conditions can induce
autophagy involving stimulated local synthesis of autophagosomes
in axons. Degradation by the autophagic process may occur in the
axons, which may require the accessibility of lysosomes or late
endosomes in the axons. Or degradation may take place in the soma,
which then requires retrograde transport of autophagosomes.
Nonetheless, the inability of axons to either degrade or transport a
large number of autophagosomes produced locally would have
deleterious consequences to the axons, causing axonal dystrophy and
degeneration (Fig. 2).
5. Speciﬁc function of p62/SQSTM1 in autophagy-mediated
protein degradation
5.1. Role of neuronal autophagy in protein homeostasis
One of the critical ﬁndings in the study of Atg5 or Atg7-
deﬁcient neurons is the recognition that autophagy is required tol autophagy maintains axonal homeostasis by removal of “autophagic cargo” (top). The
mes for degradation. Stress or injury can induce local biosynthesis of autophagosomes,
nder pathological conditions, precursors of degradative vesicles or lysosomes may be
gosomes (bottom left). Neurons deﬁcient in autophagy amass proteins, organelles, and
trophy (bottom right).
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genes causes accumulation of polyubiquitinated proteins. These
appear as inclusion bodies, which increase in size and number
with aging. However, proteasome function, which is generally
known to cause abnormal ubiquitin-mediated proteolysis when
impaired, is not compromised. Thus, blocking neuronal autophagy
results in delayed global turnover of cytoplasmic components,
accumulation of misfolded and/or unfolded proteins, followed by
ubiquitination and the formation of inclusion bodies. Furthermore,
these ﬁndings reveal an important role for basal autophagy in the
protein clearance or protein homeostasis in neurons. While
autophagy is absolutely required to degrade proteins for the
maintenance of homeostasis in healthy neurons, its function
becomes even more prominent in neurons expressing disease-
related proteins. Recent studies show that autophagy contributes
to the degradation of aggregate-prone proteins such as polygluta-
mine containing proteins and mutant alpha-synuclein [15].
Although it remains largely unclear how autophagy may achieve
selective degradation of these disease-related proteins, expression
of disease-related proteins in cells or neurons stimulates autop-
hagy activation, and elevated autophagy is correlated with reduced
levels of protein aggregates, concomitant with a decrease in
neurotoxicity [61,108].
5.2. Link of p62/SQSTM1 to autophagic degradation
Emerging evidence suggests that p62/SQSTM1, originally iden-
tiﬁed as an ubiquitin-associated protein, provides a link between
autophagy and selective protein degradation. Recent studies show
that p62/SQSTM1 is an LC3-interacting protein [103,109]. Because
p62/SQSTM1 can bind a large number of proteins through its
multiple protein–protein interaction motifs, it may mediate diverse
signaling pathways including cell stress, survival, and inﬂammation.
Structural analysis reveals that p62/SQSTM1 N-terminal Phox and
Bem1 (PB1) domain exhibits self-oligomerization, and the C-
terminal ubiquitin-associated (UBA) domain can bind ubiquitinated
proteins, suggesting a link between p62/SQSTM1 and disease-
related protein inclusion formation. Consistent with the notion that
p62/SQSTM1 is likely more related to autophagy-lysosome degra-
dation, lysosomal inhibition, but not proteasomal inhibition,
resulted in marked accumulation of p62 as well as LC3-II.
Moreover, ablation of autophagy in neurons leads to a rapid and
robust increase in p62 protein levels [54,109]. These observations
suggest that p62 is selectively degraded by autophagy via the LC3-
interaction. In addition, since autophagosome formation and long-
lived protein degradation are intact in p62-knockout mice, p62 is
considered a speciﬁc substrate of autophagy rather than a molecule
involved in autophagosome formation.
Recent studies have identiﬁed the LC3 recognition sequence
(LRS) in uncharacterized linker regions between the zinc ﬁnger and
UBA domains in murine p62. The LRS is comprised of 11 amino acids
(Ser334–Ser344), which include an acidic cluster and hydrophobic
residues (DDD or DEE and WXXL or WXXV). Interestingly, this
sequence is almost identical to a previously reported LC3-interacting
region (LIR) of human p62. The crystal structure of the LC3-LRS
complex, solved at 1.56 Å resolution, reveals that the acidic cluster of
Asp337–Asp339 in LRS interacts with basic residues in the N
terminus of LC3, and that the Trp-340 and Leu-343 residues are
inserted into two hydrophobic pockets, exposed on the ubiquitin
domain of LC3. LC3 has basic residues at its N-terminal α-helix
surface, and these residues are involved in the interaction with the
acidic cluster of LRS, whereas the other two Atg8 mammalian
homologues, GATE-16 and GABARAP, have acidic residues in their
respective N-terminal α-helical surfaces [110]. It is thus conceivable
that p62 is a more favorable target for LC3 than GATE-16
or GABARAP.5.3. Role of p62 in inclusion body formation
Characterization of protein inclusions in autophagy-deﬁcient cells
or neurons reveals that nearly all inclusions are positive for ubiquitin
and p62 [109]. This raises an important question regarding the role of
p62 in the formation of protein inclusions. To answer this, Komatsu
et al. crossed p62−/− mice to mutant mice with autophagy
deﬁciency in speciﬁc tissues. They found that loss of p62 greatly
reduces the formation of ubiquitinated protein inclusions resulting
from impaired autophagy inmice. Similar studieswere also performed
in fruit ﬂies and again the results indicate that the presence of p62 is
necessary for the occurrence of protein inclusions in neurons [111]. To
understand the molecular basis of this function of p62, it was shown
that p62 proteins harboring mutations in LRS, escape efﬁcient
degradation by autophagy, leading to inclusion formation despite
normal autophagy in cells. In addition, degradation of the PB1 mutant
of p62, which is defective in oligomerization, is markedly attenuated,
but no protein inclusions occur. These results suggest that increased
levels and oligomerization of p62 are necessary for the formation of
inclusion bodies, and furthermore, oligomerization of p62 via PB1 is a
critical event for facilitating their degradation by autophagy.
Considerable evidence has shown that p62 is a component of
protein inclusion bodies found in human disorders such as in liver
injuries (e.g., alcoholic hepatitis, steatohepatitis, and α1-antitrypsin
deﬁciency) and neurodegenerative diseases (e.g., AD, PD, and ALS).
Although autophagy is beneﬁcial in the clearance of toxic protein
aggregates and prevents cellular toxicity, whether or not p62 is indeed
essential for the formation of disease-related inclusions and the exact
role of p62 in the disease process remains unknown at present.
Intriguingly, the formation of ubiquitin-positive aggregates induced
by proteasome inhibition is also suppressed in p62-deﬁcient cells,
suggesting that p62 is a general mediator of inclusion formation. Thus,
we hypothesize that p62 normally functions as an adaptor that links
certain proteins to autophagy machinery for degradation. When
cellular degradation systems (proteasomes or autophagy-lysosomes)
are compromised or overwhelmed, p62 levels are sharply increased
(especially with impaired autophagy) and it simply behaves as “glue”
that bonds many autophagic protein substrates together, manifesting
as protein aggregates and eventually large protein inclusions.
5.4. Potential mechanism of neurodegeneration caused by
autophagy-deﬁciency
Emerging evidence indicates that soluble proto-ﬁbrils or small
oligomers of disease-related proteins are the cytotoxic species,
whereas large inclusion bodies derived from the sequestration of
toxic protein oligomers are protective. Therefore, we can hypothesize
that the presence of p62 is protective in suppressing the toxicity of
proto-ﬁbrils or protein oligomers, given the role of p62 in facilitating
the formation of relatively less toxic inclusion bodies. Accordingly, loss
of p62 in autophagy-deﬁcient neurons would exacerbate the
neurodegenerative process because toxic proteins would accumulate
intracellularly and no inclusion bodies would form. Surprisingly, in
Atg7/p62 double knockout mice, loss of p62 was found to be
associated with reduced liver dysfunction or little change in the
neurodegenerative process caused by autophagy-deﬁciency, despite
the absence of any inclusion bodies [109]. Apart from the speciﬁc
function of p62 in liver, these results seem to argue against a critical
role of protein inclusions in the context of cytotoxicity, especially in
the absence of disease-related proteins. Alternatively, they may
suggest that the proteins accumulated upon impairment of autophagy
are largely neutral or at least neurons are tolerant to the build-up of
those proteins. In this regard, the degradative function of autophagy in
protein homeostasis control is likelymore signiﬁcant towards disease-
related, aggregate-prone proteins than normal long-lived protein
substrates of autophagy.
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whenneuronal autophagy is impaired?As discussed above, analyses of
knock-out mice with Purkinje cell-speciﬁc Atg7 deletion (Atg7ﬂox/ﬂox;
Pcp2-Cre) demonstrated that loss of Atg7 initially causes cell-
autonomous, progressive dystrophy (manifested by axonal swelling)
and degeneration of the axon terminals followed by cell-autonomous
Purkinje cell death and mouse behavioural deﬁcits. Furthermore, the
mutant Purkinje cells developed aberrant organelles in the swelling
axons, suggesting the important role of autophagy in the regulation of
local axonal membrane trafﬁcking and turnover [58]. The study also
implicates impairment of axonal autophagy as a mechanism for
axonopathy associated with neurodegeneration. Interestingly, such
axonopathy associatedwith Atg7-deﬁcient Purkinje cells and hypotha-
lamic neurons is still observed in Atg7/p62-double knockout neurons,
indicating that the development of axonopathy in Atg7-deﬁcient
neurons is p62-independent [109]. Therefore, we hypothesize that
axonal dystrophy and degeneration provide an important mechanism
for the neurodegeneration caused by autophagy-deﬁciency.
6. Conclusion and perspectives
The past several years havewitnessed a rapid growth of autophagy
research. With emerging evidence that links the aberrant autophagic
activity to various neurodegenerative diseases, it is of upmost
importance to understand the basic process of neuronal autophagy
at molecular and cellular levels. This would aid in revealing the exact
role of autophagy in the neuropathogenesis associated with different
diseases. Currently, the particular challenge facing us is to establish
robust and physiological cellular and animal models that allow us to
dissect neuronal autophagy, and to identify speciﬁc factors that
contribute to the regulation of neuronal autophagy process. We
anticipate that, with the development of new experimental
approaches, particularly in the area of cell biology, mouse genetics,
live-imaging and proteomics, we will make signiﬁcant progress in this
ﬁeld and provide valuable knowledge to the design of drugs targeted
at autophagy in the treatment of neurodegenerative diseases.
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